home / stock / phio / phio news


PHIO News and Press, Phio Pharmaceuticals Corp.

Stock Information

Company Name: Phio Pharmaceuticals Corp.
Stock Symbol: PHIO
Market: NASDAQ
Website: phiopharma.com

Menu

PHIO PHIO Quote PHIO Short PHIO News PHIO Articles PHIO Message Board
Get PHIO Alerts

News, Short Squeeze, Breakout and More Instantly...

PHIO - Phio Pharmaceuticals GAAP EPS of -$1.45 beats by $0.31

2026-03-05 17:11:14 ET More on Phio Pharmaceuticals Seeking Alpha’s Quant Rating on Phio Pharmaceuticals Historical earnings data for Phio Pharmaceuticals Financial information for Phio Pharmaceuticals Read the full article on Seeking Alpha For...

PHIO - Phio Pharmaceuticals Reports 2025 Year-End Financial Results and Business Update

Treatment Phase for Lead Clinical Candidate PH-762 Dose Escalation Trial is Complete with Favorable Safety, Tolerability and Pathology Data 2025 Financings and Warrant Exercises Strengthen Balance Sheet with $23.7 Million in Net Proceeds, Extending Cash Runway into the First Half of 2027 Ki...

PHIO - US Companies Moving the Markets, Morning edition
Thu, Feb 19, 2026 as of 10.00 am ET

A look at the top 10 most actives in the United States Direxion Daily Semiconductor Bear 3X Shares (SOXS) fell 3.4% to $1.71 on volume of 583,873,529 shares Rackspace Technology Inc. (RXT) rose 227.0% to $1.37 on volume of 542,491,528 shares RenX Enterprises Corp. (RENX) rose 44.9% to $0.19...

PHIO - Phio Pharmaceuticals Aligns Leadership Team to Support Next Stage Development of PH-762 and Advancement of PH-894

Leadership Enhancements Position Company for Upcoming Regulatory Engagement and Clinical Milestones New Appointments Reinforce Operational Readiness Across Finance, Regulatory Affairs and Program Leadership King of Prussia, Pennsylvania--(Newsfile Corp. - February 19, 2026) - Phio Pharmaceut...

PHIO - US Companies Moving the Markets, Evening edition
Wed, Feb 18, 2026 as of 4:00 pm ET

A look at the top 10 most actives in the United States Direxion Daily Semiconductor Bear 3X Shares (SOXS) fell 0.8% to $1.755 on volume of 511,769,332 shares Rackspace Technology Inc. (RXT) rose 216.2% to $1.325 on volume of 500,182,029 shares RenX Enterprises Corp. (RENX) rose 41.5% to $0....

PHIO - US Companies Moving the Markets, Evening edition
Fri, Feb 13, 2026 as of 4:00 pm ET

A look at the top 10 most actives in the United States Direxion Daily Semiconductor Bear 3X Shares (SOXS) fell 2.5% to $1.765 on volume of 586,454,072 shares Iveda Solutions Inc. (IVDA) rose 18.2% to $0.3429 on volume of 194,121,230 shares ProShares UltraShort Silver -2x Shares (ZSL) fell 6...

PHIO - US Companies Moving the Markets, Morning edition
Wed, Feb 11, 2026 as of 10.00 am ET

A look at the top 10 most actives in the United States Quince Therapeutics Inc. (QNCX) rose 305.9% to $0.5277 on volume of 1,593,495,428 shares Direxion Daily Semiconductor Bear 3X Shares (SOXS) rose 0.6% to $1.82 on volume of 450,429,782 shares ProShares UltraShort Silver -2x Shares (ZSL) ...

PHIO - US Companies Moving the Markets, Evening edition
Tue, Feb 10, 2026 as of 4:00 pm ET

A look at the top 10 most actives in the United States Quince Therapeutics Inc. (QNCX) rose 336.9% to $0.567999 on volume of 1,334,472,413 shares Direxion Daily Semiconductor Bear 3X Shares (SOXS) rose 1.4% to $1.835 on volume of 405,466,147 shares Phio Pharmaceuticals Corp. (PHIO) rose 28....

PHIO - Phio Announces Safety Monitoring Committee's (SMC) Positive Wrap-up on Lead Clinical Candidate PH-762 in Skin Cancer Trial

Maximum Dose Concentration in Final Cohort Yields 85% Pathological Response (6 of 7 Patients); Complete Response (100% Tumor Clearance) in 4 of 6 Responders No Serious Adverse Events or Dose-Limiting Toxicities Identified Across All 5 Dose Escalation Cohorts King of Prussia, Pennsylvania--(N...

PHIO - Phio Pharmaceuticals Announces Participation in Third Annual DealFlow Discovery Conference

Phio's Presentation to take place on Wednesday January 28, 2026 at 9 AM ET King of Prussia, Pennsylvania--(Newsfile Corp. - January 26, 2026) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage siRNA biopharmaceutical company developing therapeutics using its proprietary INTASYL ...

Next 10